Miguel Maria Graça, Gago Custódia, Antunes Maria Dulce, Lagoas Soraia, Faleiro Maria Leonor, Megías Cristina, Cortés-Giraldo Isabel, Vioque Javier, Figueiredo Ana Cristina
Departamento de Química e Farmácia, Faculdade de Ciências e Tecnologia, Universidade do Algarve, MeditBio, Campus de Gambelas, 8005-139 Faro, Portugal.
MeditBio, Faculdade de Ciências e Tecnologia, Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.
Medicines (Basel). 2018 Jun 21;5(3):61. doi: 10.3390/medicines5030061.
Essential oils (EOs) have shown antimicrobial, antioxidant, and antiproliferative activity, which may, alone or in combination with other substances, potentially be used for the development of new drugs. However, their chemical variability, depending on the species, varieties, or geographical origin (among other factors) determines different bioactivities that need to be evaluated. The antioxidant activity of and eight species EOs was determined using two different methods: the scavenging ability of 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) and peroxyl free radicals or oxygen radical absorbance capacity (ORAC). Antibacterial activity was evaluated using the microorganisms (strains D39 and TIGR4), and (strain DSM 9999). The essential oils’ minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) was assessed using a microdilution method. The antiproliferative activity was determined using the THP-1 cell line (human acute monocytic leukaemia) with methylthiazolyldiphenyl-tetrazolium bromide assay (MTT). and EOs showed the highest ABTS and peroxyl free radical scavenging capacity. EO showed a high potential to treat infections. was the respiratory pathogen that showed the highest resistance to all EOs, including tea tree EO. After 96 h of incubation, at 25 μg/mL, and EOs showed highest cytotoxic activity against the THP-1 cell line. Despite their specific bioactivities, no single EO showed simultaneously good antioxidant, antimicrobial, and antiproliferative activity.
精油(EOs)已显示出抗菌、抗氧化和抗增殖活性,其单独或与其他物质联合使用,有可能用于开发新药。然而,其化学变异性取决于物种、品种或地理来源(以及其他因素),这决定了需要评估的不同生物活性。使用两种不同方法测定了[具体名称未给出]和8种[具体名称未给出]物种精油的抗氧化活性:2,2′-联氮-双-(3-乙基苯并噻唑啉-6-磺酸)(ABTS)和过氧自由基清除能力或氧自由基吸收能力(ORAC)。使用微生物[具体名称未给出](菌株D39和TIGR4)和[具体名称未给出](菌株DSM 9999)评估抗菌活性。采用微量稀释法评估精油的最低抑菌浓度(MIC)和最低杀菌浓度(MBC)。使用噻唑蓝溴化四氮唑(MTT)法,通过THP-1细胞系(人急性单核细胞白血病)测定抗增殖活性。[具体名称未给出]和[具体名称未给出]精油显示出最高的ABTS和过氧自由基清除能力。[具体名称未给出]精油显示出治疗[具体名称未给出]感染的高潜力。[具体名称未给出]是对包括茶树精油在内的所有精油耐药性最高的呼吸道病原体。在25μg/mL浓度下孵育96小时后,[具体名称未给出]和[具体名称未给出]精油对THP-1细胞系显示出最高的细胞毒性活性。尽管它们具有特定的生物活性,但没有一种单一精油同时显示出良好的抗氧化、抗菌和抗增殖活性。